Researchers at the University of Liverpool have found that the weight-loss drug tirzepatide is associated with a significantly reduced risk of developing type 2 diabetes (T2D).
This article was originally published on MedicalXpress.com
Study sees potential benefits of obesity drug tirzepatide in tackling type 2 diabetes
You may also be interested in:
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
Read More:
-
Four in 10 children in Central London who traveled to school by car switched to more active modes of transport, such as walking, cycling, or [...]
-
What parent hasn’t been there? It’s been a long day, you still have dinner to make, maybe lunches for tomorrow too, and you just don’t [...]
-
Children born in July and August are at least 40% more likely to be diagnosed with—and to receive prescriptions for—attention deficit hyperactivity disorder (ADHD), than [...]
